Sara McCutchan

Director, Regulatory & Quality at Aristea Therapeutics

Sara McCutchan, Senior Regulatory Affairs Manager, has significant regulatory and quality assurance expertise in global marketing authorizations in diverse markets. Prior to joining Aristea, she played an integral role in the Regulatory Affairs function at Ardea Biosciences where she obtained and managed marketing authorizations in the US, EU, Latin America, Australia, and New Zealand. Sara has proven experience in managing projects and people across a range of providers and licensing partners. In addition to her Regulatory Affairs role at Ardea, Sara spent several years in Quality Assurance where she supported three successful FDA inspections, managed internal quality systems, and employee training.

Sara holds a BS in Cognitive Science from the University of California, San Diego and has a Regulatory Affairs Certification (RAC).


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Aristea Therapeutics

Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea’s lead program, RIST4721, is currently in Phase 2 clinical development.


Industries

Employees

1-10

Links